Acute deterioration of Charcot-Marie-Tooth disease IA (CMTIA) following 2 mg of vincristine chemotherapy
Open Access
- 1 June 2000
- journal article
- case report
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6) , 743-747
- https://doi.org/10.1023/a:1008369315240
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve MyelinNeuron, 1996
- Vincristine neuropathy in type I and type II charcot‐marie‐tooth disease (hereditary motor sensory neuropathy)Medical and Pediatric Oncology, 1995
- Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: a review.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Charcot–marie–tooth neuropathies: From clinical description to molecular geneticsMuscle & Nerve, 1995
- Peripheral myelin protein 22: Facts and hypothesesJournal of Neuroscience Research, 1995
- Connexin Mutations in X-Linked Charcot-Marie-Tooth DiseaseScience, 1993
- L2/HNK‐1 carbohydrate and protein‐protein interactions mediate the homophilic binding of the neural adhesion molecule P0Journal of Neuroscience Research, 1992
- Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unitNature Genetics, 1992
- DNA duplication associated with Charcot-Marie-Tooth disease type 1ACell, 1991
- Studies on the pathogenesis of vincristine‐induced neuropathyMuscle & Nerve, 1987